학술논문
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Document Type
Article
Author
Source
In: Blood Advances . (Blood Advances, June 2023, 7(12):2670-2676)
Subject
Language
English
ISSN
24739537
24739529
24739529